Latest NTLA reports update at 2024-05-09: 2024-Q12023-Q42023-Q1
Intellia Therapeutics logo
Intellia Therapeutics NTLA
$ 24.86 8.09%

Intellia Therapeutics P/E Ratio 2011-2024 | NTLA

Annual P/E Ratio Intellia Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-5.05 -6.29 -25 -26.1 -1.19 -6.94 -13.8 -8.82 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.19 -26.1 -11.7